Anova Biomedical, a Cornell spinout developing biodegradable vascular grafts, recently joined the university’s Center for Life Science Ventures.
Co-founders Anthony D’Amato, a former postdoctoral researcher, and Yadong Wang, the McAdam Family Foundation Professor of Heart Assist Technology in the Meinig School of Biomedical Engineering, developed the innovation through research in Wang’s lab. So far, Anova has licensed 11 patents from the lab, including intellectual property in composition, design and manufacturing.
D’Amato, now CEO, graduated from the first cohort of the Ignite Fellow for New Ventures program in August 2024, leading to the formation of Anova Biomedical.
